Journal of Aerosol Medicine and Pulmonary Drug Delivery

Edit Your Profile

Journal of Aerosol Medicine and Pulmonary Drug Delivery Journal

publication venue for

Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery. 37:202-218. 2024
Design, Characterization, and Aerosol Dispersion Performance Modeling of Advanced Spray-Dried Microparticulate/Nanoparticulate Mannitol Powders for Targeted Pulmonary Delivery as Dry Powder Inhalers. 27:81-93. 2014
IMPROVING PHYSICAL AND AEROSOL STABILITY OF SPRAY DRIED HIGH-DOSE DRY POWDER INHALER FORMULATIONS 2022
TARGETING DEEP LUNGS WITH SWELLABLE NANO/MICROGELS FOR THE DELIVERY OF SURAMIN 2022
A STELLA SIMULATION MODEL FOR IN VITRO DISSOLUTION TESTING OF RESPIRABLE SIZE PARTICLES 2021
A TRIPLE COMBINATION ANTI-TUBERCULAR DRY POWDER FORMULATION FOR TREATING BOTH DRUG SUSCEPTIBLE AND MULTIDRUG RESISTANT TUBERCULOSIS: FORMULATION AND IN VITRO CHARACTERIZATION 2018
COCRYSTAL APPROACH TO REDUCE THE AQUEOUS SOLUBILITY AND DISSOLUTION RATE FOR IMPROVED RESIDENCE TIME OF AN ANTI-TUBERCULAR DRUG IN THE LUNGS 2018
THE INFLUENCE OF LUNG SURFACTANT, 1,2-DIPALMITOYL-SN-GLYCERO-3PHOSPHATIDYLCHOLINE (DPPC) ON THE AEROSOLIZATION OF TWO ANTI-TUBERCULAR DRUGS, PYRAZINAMIDE AND MOXIFLOXACIN 2017
COMPARISON OF IN VITRO AEROSOL DISPERSION PERFORMANCE USING DIFFERENT DRY POWDER INHALER DEVICES 2017
IMPROVEMENT OF THE IN VITRO AEROSOL DISPERSION PERFORMANCE OF SIMVASTATIN BY CO-SPRAY DRYING WITH D-MANNITOL FOR THE TREATMENT OF PULMONARY HYPERTENSION 2017
Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking Group 2020
Inhalable and Nasal Biologics: Analytical, Formulation, Development, and Regulatory Considerations 2025

International Standard Serial Number (ISSN)

1941-2711

Electronic International Standard Serial Number (EISSN)

1941-2703